Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance

[1]  Maria Matarese,et al.  mTOR-dependent phosphorylation controls TFEB nuclear export , 2018, Nature Communications.

[2]  Xiaoyu Liang,et al.  Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype , 2018, Nature Communications.

[3]  Liang Cheng,et al.  Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine , 2017, Modern Pathology.

[4]  G. Mills,et al.  A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles. , 2017, Cancer discovery.

[5]  P. Mallick,et al.  JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines , 2017, Molecular Cancer Therapeutics.

[6]  B. Razani,et al.  Transcriptional factor EB regulates macrophage polarization in the tumor microenvironment , 2017, Oncoimmunology.

[7]  J. Neilson,et al.  mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases , 2017, Nature Communications.

[8]  M. Weller,et al.  Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells , 2016, Oncotarget.

[9]  Chonglin Yang,et al.  Protein kinase C controls lysosome biogenesis independently of mTORC1 , 2016, Nature Cell Biology.

[10]  V. Promponas,et al.  iLIR database: A web resource for LIR motif-containing proteins in eukaryotes , 2016, Autophagy.

[11]  H. Brenner,et al.  Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. , 2016, Gastroenterology.

[12]  E. Sokol,et al.  AMPK promotes tolerance to Ras pathway inhibition by activating autophagy , 2016, Oncogene.

[13]  Arati Sharma,et al.  Current State of Animal (Mouse) Modeling in Melanoma Research , 2015, Cancer growth and metastasis.

[14]  K. Ross,et al.  Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism , 2015, Nature.

[15]  E. White,et al.  Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma. , 2015, Cancer discovery.

[16]  A. Ballabio,et al.  Lysosomal calcium signaling regulates autophagy via calcineurin and TFEB , 2015, Nature Cell Biology.

[17]  A. Rust,et al.  BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model , 2015, Proceedings of the National Academy of Sciences.

[18]  Q. Zhong.  Faculty Opinions recommendation of Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. , 2015 .

[19]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[20]  A. Ballabio,et al.  Induction of Lysosomal Biogenesis in Atherosclerotic Macrophages Can Rescue Lipid-Induced Lysosomal Dysfunction and Downstream Sequelae , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[21]  Frank McCormick,et al.  Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond , 2014, Nature Reviews Cancer.

[22]  A. Alavi,et al.  Combined MTOR and autophagy inhibition , 2014, Autophagy.

[23]  R. Bernards,et al.  Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma , 2014, Nature.

[24]  M. Herlyn,et al.  Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. , 2014, The Journal of clinical investigation.

[25]  H. Simon,et al.  Autophagy suppresses melanoma tumorigenesis by inducing senescence , 2014, Autophagy.

[26]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[27]  J. Martina,et al.  The Nutrient-Responsive Transcription Factor TFE3 Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular Debris , 2014, Science Signaling.

[28]  R. Bernards,et al.  TGF-β: An emerging player in drug resistance , 2013, Cell cycle.

[29]  S. Knapp,et al.  Copper is required for oncogenic BRAF signaling and tumorigenesis , 2013, Nature.

[30]  A. Kamat,et al.  ZKSCAN3 is a master transcriptional repressor of autophagy. , 2013, Molecular cell.

[31]  Matthew Meyerson,et al.  A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1 , 2013, Science.

[32]  J. Martina,et al.  Rag GTPases mediate amino acid–dependent recruitment of TFEB and MITF to lysosomes , 2013, The Journal of cell biology.

[33]  K. Guan,et al.  Amino acid signalling upstream of mTOR , 2013, Nature Reviews Molecular Cell Biology.

[34]  D. Rubinsztein,et al.  Autophagy modulation as a potential therapeutic target for diverse diseases , 2012, Nature Reviews Drug Discovery.

[35]  T. Walther,et al.  The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.

[36]  P. Chaudhary,et al.  A Computational Profiling of Changes in Gene Expression and Transcription Factors Induced by vFLIP K13 in Primary Effusion Lymphoma , 2012, PloS one.

[37]  Yong Chen,et al.  MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB , 2012, Autophagy.

[38]  T. Gilmer,et al.  Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations , 2012, Molecular Cancer Therapeutics.

[39]  A. Ballabio,et al.  A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.

[40]  Meenhard Herlyn,et al.  Resistance to BRAF inhibitors: unraveling mechanisms and future treatment options. , 2011, Cancer research.

[41]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[42]  G. Mann,et al.  Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Nelson,et al.  Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.

[44]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[45]  K. Hoek,et al.  GLI2-mediated melanoma invasion and metastasis. , 2010, Journal of the National Cancer Institute.

[46]  B. Taylor,et al.  The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner , 2010, Proceedings of the National Academy of Sciences.

[47]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[48]  J. Thiery.  [Epithelial-mesenchymal transitions in cancer onset and progression]. , 2009, Bulletin de l'Academie nationale de medecine.

[49]  S. Pattingre,et al.  JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. , 2008, Molecular cell.

[50]  Kam Y. J. Zhang,et al.  Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.

[51]  Robin Mathew,et al.  Role of autophagy in cancer , 2007, Nature Reviews Cancer.

[52]  E. White,et al.  Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. , 2007, Genes & development.

[53]  E. White,et al.  Autophagy suppresses tumor progression by limiting chromosomal instability. , 2007, Genes & development.

[54]  J. Urano,et al.  Point mutations in TOR confer Rheb-independent growth in fission yeast and nutrient-independent mammalian TOR signaling in mammalian cells , 2007, Proceedings of the National Academy of Sciences.

[55]  E. White,et al.  Role of Autophagy in Cancer: Management of Metabolic Stress , 2007, Autophagy.

[56]  Kevin Bray,et al.  Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. , 2006, Cancer cell.

[57]  T. Kinoshita,et al.  Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. , 2005, Biochemical and biophysical research communications.

[58]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[59]  B. Doble,et al.  GSK-3: tricks of the trade for a multi-tasking kinase , 2003, Journal of Cell Science.

[60]  Takeshi Noda,et al.  LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing , 2000, The EMBO journal.

[61]  M. Skobe,et al.  Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. , 1999, The American journal of pathology.

[62]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[63]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[64]  P. Seglen,et al.  3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[65]  D. Medina,et al.  TFEB and the CLEAR network. , 2015, Methods in cell biology.

[66]  Dennis C. Friedrich,et al.  MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition. , 2014, Cancer discovery.

[67]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.